Viewing Study NCT00633802

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:46 AM
Ignite Modification Date: 2026-02-21 @ 3:22 PM
Study NCT ID: NCT00633802
Status: UNKNOWN
Last Update Posted: 2008-03-12
First Post: 2008-03-04
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Low-Dose Risperidone Treatment for Subjects Suffering From Borderline Personality Disorder
Sponsor: Tel-Aviv Sourasky Medical Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Borderlone Personality Disorder View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Risperidone View
None Borderlone Personality Disorder View